Protara Therapeutics Q4 EPS $(0.90) Beats $(0.92) Estimate
Portfolio Pulse from Happy Mohamed
Protara Therapeutics reported Q4 earnings with losses of $(0.90) per share, slightly better than the expected $(0.92), but a 7.14% increase in losses compared to the same period last year.
March 13, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Protara Therapeutics reported a smaller-than-expected quarterly loss, but with an increase in losses year-over-year.
While beating the analyst consensus estimates might be viewed positively, the increase in losses year-over-year could temper investor enthusiasm. The mixed results make the short-term impact neutral.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100